As of December 2024, Cogent Biosciences has a market cap of $675.21M. This makes Cogent Biosciences the world's 9959th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $777.70M | 53.57% |
2023 | $506.41M | -49.13% |
2022 | $995.60M | 34.73% |
2021 | $738.95M | -23.60% |
2020 | $967.17M | 289.93% |
2019 | $248.04M | -83.64% |
2018 | $1.52B | - |